Type of Health Care Encounter | |||||||||
---|---|---|---|---|---|---|---|---|---|
Type of Site | Hospitalizations and ED visits | Hospitalizations | ED visits | ||||||
 | RV5 # (rate)a of events | Placebo # (rate)a of events | % Rate Reduction (95% CI) | RV5 # (rate)a of events> | Placebo # (rate)a of events | % Rate Reduction (95% CI) | RV5 # (rate)a of events | Placebo # (rate)a of events | % Rate Reduction (95% CI) |
Sites in the Efficacy Substudy | |||||||||
RVGE | 10 (4.3) | 128 (51.8) | 91.0 (81.7, 95.5) | 1 (0.4) | 27 (10.9) | 95.7 (68.5, 99.4) | 9 (3.8) | 101 (40.9) | 89.7 (78.1, 95.1) |
AGE | 280 (76.2) | 483 (131.4) | 39.7 (28.0, 49.5) | 31 (8.4) | 95 (25.8) | 66.1 (48.0, 77.8) | 249 (67.8) | 388 (105.5) | 33.2 (18.9, 45.1) |
Sites not in the Efficacy Substudy | |||||||||
RVGE | 10 (0.6) | 241 (15.6) | 95.9 (92.2, 97.8) | 5 (0.3) | 117 (7.6) | 95.8 (89.6, 98.3) | 5 (0.3) | 124 (8.0) | 96.0 (90.2, 98.4) |
AGE | 815 (31.6) | 1385 (53.8) | 41.2 (35.0, 46.8) | 206 (8.0) | 480 (18.7) | 57.1 (49.0, 64.0) | 609 (23.6) | 905 (35.2) | 32.8 (24.2, 40.4) |